BIO.MASTER.BioMonitor 2 Study
NCT02565238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2017-05-08
Summary
The objective of the study is to confirm safety and efficacy of the BioMonitor 2. The data is collected to support the regulatory approval of this product in countries outside the CE region.
Conditions
- Tachyarrhythmia
- Atrial Fibrillation
- Syncope
Interventions
- DEVICE
-
BioMonitor 2
Implantation of BioMonitor 2
Sponsors & Collaborators
-
Biotronik SE & Co. KG
lead INDUSTRY
Principal Investigators
-
Christopher Piorkowski, MD · Heart Center Dresden, Germany
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-10-31
- Completion
- 2017-02-28
More Related Trials
-
Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products
NCT05560958 ·Status: RECRUITING
-
ProMRI 3T ENHANCED Master Study
NCT02506569 ·Status: COMPLETED
-
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084 ·Status: RECRUITING
-
MARC-2: MARKERS AND RESPONSE TO CRT in Non-LBBB
NCT04120909 ·Status: UNKNOWN
-
Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
NCT05621187 ·Status: COMPLETED ·Phase: NA
-
A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation
NCT02623517 ·Status: COMPLETED
-
Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka
NCT07020910 ·Status: RECRUITING
-
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
NCT05505136 ·Status: COMPLETED
-
Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study
NCT02849769 ·Status: COMPLETED
-
BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction
NCT02341534 ·Status: COMPLETED ·Phase: NA
-
Identification for the Treatment of Complex Arrhythmias
NCT02565069 ·Status: COMPLETED ·Phase: PHASE4
-
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
NCT06352060 ·Status: COMPLETED
-
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531 ·Status: COMPLETED ·Phase: PHASE4
-
PANORAMA 2 Observational Study
NCT01723566 ·Status: COMPLETED
-
Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker
NCT00916344 ·Status: COMPLETED ·Phase: NA
-
Chronic Evaluation of Novel Pacemaker System
NCT06056817 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems
NCT01774357 ·Status: COMPLETED
-
Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
NCT03891329 ·Status: COMPLETED ·Phase: NA
-
Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF
NCT00158951 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
NCT00559988 ·Status: TERMINATED ·Phase: PHASE4
-
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System
NCT01965899 ·Status: COMPLETED ·Phase: NA
-
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
NCT05643235 ·Status: RECRUITING ·Phase: NA
-
BIO-2-HEART: Identification of Biomarkers in T2DM and Heart Failure
NCT03323216 ·Status: RECRUITING
-
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
NCT04421040 ·Status: COMPLETED ·Phase: NA
-
Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization
NCT03253809 ·Status: TERMINATED ·Phase: NA